Form 8-K - Current report:
SEC Accession No. 0001493152-22-019765
Filing Date
2022-07-19
Accepted
2022-07-19 09:19:27
Documents
18
Period of Report
2022-07-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50077
2 ex10-1.htm EX-10.1 133717
3 ex10-2.htm EX-10.2 136249
4 ex99-1.htm EX-99.1 14617
5 ex99-1_001.jpg GRAPHIC 32415
6 ex99-2.htm EX-99.2 9741
7 ex99-2_001.jpg GRAPHIC 32415
  Complete submission text file 0001493152-22-019765.txt   670586

Data Files

Seq Description Document Type Size
8 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsn-20220719.xsd EX-101.SCH 2956
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsn-20220719_lab.xml EX-101.LAB 34240
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsn-20220719_pre.xml EX-101.PRE 22357
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3615
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 221090506
SIC: 2834 Pharmaceutical Preparations